Prostate cancer biomarkers: new scenarios in the multi-parametric magnetic resonance imaging era.

The article discusses the benefits of multi-parametric magnetic resonance imaging (mpMRI) in detecting the clinical manifestation for prostate cancer. However, mpMRI is expensive, labor-intensive and time-consuming reporting, and is not feasible for screening purposes in men at risk of prostate cancer. The authors believe that both prostatectomy and fusion biopsy remain preferable in evaluating diagnostic accuracy of prostate cancer biomarkers.